140 related articles for article (PubMed ID: 32731542)
1. Conformational Equilibrium of NADPH-Cytochrome P450 Oxidoreductase Is Essential for Heme Oxygenase Reaction.
Sugishima M; Taira J; Sagara T; Nakao R; Sato H; Noguchi M; Fukuyama K; Yamamoto K; Yasunaga T; Sakamoto H
Antioxidants (Basel); 2020 Jul; 9(8):. PubMed ID: 32731542
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase.
Sugishima M; Sato H; Higashimoto Y; Harada J; Wada K; Fukuyama K; Noguchi M
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2524-9. PubMed ID: 24550278
[TBL] [Abstract][Full Text] [Related]
3. The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase. Electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN.
Higashimoto Y; Sato H; Sakamoto H; Takahashi K; Palmer G; Noguchi M
J Biol Chem; 2006 Oct; 281(42):31659-67. PubMed ID: 16928691
[TBL] [Abstract][Full Text] [Related]
4. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
[TBL] [Abstract][Full Text] [Related]
5. Involvement of NADPH in the interaction between heme oxygenase-1 and cytochrome P450 reductase.
Higashimoto Y; Sakamoto H; Hayashi S; Sugishima M; Fukuyama K; Palmer G; Noguchi M
J Biol Chem; 2005 Jan; 280(1):729-37. PubMed ID: 15516695
[TBL] [Abstract][Full Text] [Related]
6. Reduction of oxaporphyrin ring of CO-bound α-verdoheme complexed with heme oxygenase-1 by NADPH-cytochrome P450 reductase.
Sato H; Higashimoto Y; Sakamoto H; Sugishima M; Shimokawa C; Harada J; Palmer G; Noguchi M
J Inorg Biochem; 2011 Feb; 105(2):289-96. PubMed ID: 21194630
[TBL] [Abstract][Full Text] [Related]
7. Coupled motions direct electrons along human microsomal P450 Chains.
Pudney CR; Khara B; Johannissen LO; Scrutton NS
PLoS Biol; 2011 Dec; 9(12):e1001222. PubMed ID: 22205878
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH/NADP
Sugishima M; Sato H; Wada K; Yamamoto K
FEBS Lett; 2019 Apr; 593(8):868-875. PubMed ID: 30883732
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Understanding of the Reaction Chemistries of the Heme Catabolizing Enzymes HO and BVR Based on High Resolution Protein Structures.
Sugishima M; Wada K; Fukuyama K
Curr Med Chem; 2020; 27(21):3499-3518. PubMed ID: 30556496
[TBL] [Abstract][Full Text] [Related]
10. Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
Chou YT; Hsu FF; Hu DY; Chen YC; Hsu YH; Hsu JT; Chau LY
J Biomed Sci; 2018 Jan; 25(1):6. PubMed ID: 29361943
[TBL] [Abstract][Full Text] [Related]
11. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding.
Gutierrez A; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2002 Apr; 41(14):4626-37. PubMed ID: 11926825
[TBL] [Abstract][Full Text] [Related]
12. Determination of the redox potentials and electron transfer properties of the FAD- and FMN-binding domains of the human oxidoreductase NR1.
Finn RD; Basran J; Roitel O; Wolf CR; Munro AW; Paine MJ; Scrutton NS
Eur J Biochem; 2003 Mar; 270(6):1164-75. PubMed ID: 12631275
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain.
Iyanagi T
Biochem Biophys Res Commun; 2005 Dec; 338(1):520-8. PubMed ID: 16125667
[TBL] [Abstract][Full Text] [Related]
14. C-Terminal membrane spanning region of human heme oxygenase-1 mediates a time-dependent complex formation with cytochrome P450 reductase.
Huber Iii WJ; Scruggs BA; Backes WL
Biochemistry; 2009 Jan; 48(1):190-7. PubMed ID: 19123922
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1 affects cytochrome P450 function through the formation of heteromeric complexes: Interactions between CYP1A2 and heme oxygenase-1.
Connick JP; Reed JR; Cawley GF; Backes WL
J Biol Chem; 2021; 296():100030. PubMed ID: 33148696
[TBL] [Abstract][Full Text] [Related]
16. The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners.
Esteves F; Campelo D; Gomes BC; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
Front Pharmacol; 2020; 11():299. PubMed ID: 32256365
[TBL] [Abstract][Full Text] [Related]
17. The Hinge Segment of Human NADPH-Cytochrome P450 Reductase in Conformational Switching: The Critical Role of Ionic Strength.
Campelo D; Lautier T; Urban P; Esteves F; Bozonnet S; Truan G; Kranendonk M
Front Pharmacol; 2017; 8():755. PubMed ID: 29163152
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.
Wang M; Roberts DL; Paschke R; Shea TM; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8411-6. PubMed ID: 9237990
[TBL] [Abstract][Full Text] [Related]
19. Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase.
Linnenbaum M; Busker M; Kraehling JR; Behrends S
PLoS One; 2012; 7(4):e35483. PubMed ID: 22545110
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase.
Higashimoto Y; Sugishima M; Sato H; Sakamoto H; Fukuyama K; Palmer G; Noguchi M
Biochem Biophys Res Commun; 2008 Mar; 367(4):852-8. PubMed ID: 18194664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
